Crossmark Global Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Crossmark Global Holdings, Inc.

$5.5 Billion
Q1 2025

A detailed history of Crossmark Global Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 2,408 shares of REGN stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,408

Previous 2,654 9.27%

Holding current value

$1.34 Million

Previous $1.89 Million 19.21%

% of portfolio

0.03%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$634.14 - $744.83 $155,998 - $183,228	-246 Reduced 9.27%	2,408 $1.53 Million
Q4 2024 Jan 16, 2025	BUY	$701.85 - $1046.91 $64,570 - $96,315	92 Added 3.59%	2,654 $1.89 Million
Q3 2024 Nov 04, 2024	SELL	$1024.09 - $1201.76 $74,758 - $87,728	-73 Reduced 2.77%	2,562 $2.69 Million
Q2 2024 Jul 29, 2024	SELL	$883.2 - $1071.19 $2,649 - $3,213	-3 Reduced 0.11%	2,635 $2.77 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $37,912 - $41,720	-42 Reduced 1.57%	2,638 $2.54 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $25,580 - $29,096	-33 Reduced 1.22%	2,680 $2.35 Million
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $50,548 - $61,639	-73 Reduced 2.62%	2,713 $2.27 Million
Q2 2023 Jul 31, 2023	BUY	$700.03 - $830.35 $35,701 - $42,347	51 Added 1.86%	2,786 $2.08 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $91,185 - $110,813	-134 Reduced 4.67%	2,735 $2.25 Million
Q4 2022 Jan 19, 2023	BUY	$705.89 - $766.39 $22,588 - $24,524	32 Added 1.13%	2,869 $2.07 Million
Q3 2022 Nov 01, 2022	SELL	$573.97 - $724.32 $152,102 - $191,944	-265 Reduced 8.54%	2,837 $1.95 Million
Q2 2022 Jul 29, 2022	BUY	$548.35 - $738.84 $29,062 - $39,158	53 Added 1.74%	3,102 $1.83 Million
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $118,428 - $138,987	-199 Reduced 6.13%	3,049 $2.13 Million
Q4 2021 Jan 10, 2022	BUY	$543.48 - $670.97 $114,130 - $140,903	210 Added 6.91%	3,248 $2.05 Million
Q3 2021 Oct 21, 2021	SELL	$574.03 - $680.96 $1.07 Million - $1.27 Million	-1,872 Reduced 38.13%	3,038 $1.84 Million
Q3 2021 Oct 13, 2021	BUY	$574.03 - $680.96 $1.05 Million - $1.25 Million	1,829 Added 59.36%	4,910 $750,000
Q2 2021 Jul 21, 2021	SELL	$472.8 - $558.54 $103,543 - $122,320	-219 Reduced 6.64%	3,081 $1.72 Million
Q1 2021 Apr 15, 2021	BUY	$446.73 - $548.2 $71,476 - $87,712	160 Added 5.1%	3,300 $1.56 Million
Q4 2020 Jan 14, 2021	BUY	$478.3 - $607.98 $956 - $1,215	2 Added 0.06%	3,140 $1.52 Million
Q3 2020 Oct 08, 2020	BUY	$544.75 - $658.21 $35,953 - $43,441	66 Added 2.15%	3,138 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $258,006 - $336,770	523 Added 20.52%	3,072 $1.92 Million
Q1 2020 Apr 28, 2020	SELL	$336.18 - $494.43 $72,278 - $106,302	-215 Reduced 7.78%	2,549 $1.24 Million
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $10,142 - $13,930	-37 Reduced 1.32%	2,764 $1.04 Million
Q3 2019 Oct 09, 2019	SELL	$273.46 - $318.39 $179,116 - $208,545	-655 Reduced 18.95%	2,801 $777,000
Q2 2019 Jul 09, 2019	SELL	$299.6 - $414.82 $606,090 - $839,180	-2,023 Reduced 36.92%	3,456 $1.08 Million
Q1 2019 May 02, 2019	SELL	$372.08 - $439.57 $134,692 - $159,124	-362 Reduced 6.2%	5,479 $2.25 Million
Q4 2018 Jan 31, 2019	SELL	$335.82 - $403.04 $588,692 - $706,529	-1,753 Reduced 23.08%	5,841 $2.18 Million
Q3 2018 Nov 08, 2018	SELL	$351.14 - $408.51 $301,278 - $350,501	-858 Reduced 10.15%	7,594 $3.07 Million
Q2 2018 Jul 31, 2018	BUY	$284.6 - $344.99 $284 - $344	1 Added 0.01%	8,452 $2.92 Million
Q1 2018 Apr 16, 2018	SELL	$315.82 - $393.78 $275,395 - $343,376	-872 Reduced 9.35%	8,451 $2.91 Million
Q4 2017 Feb 05, 2018	BUY	$358.63 - $469.95 $629,395 - $824,762	1,755 Added 23.19%	9,323 $3.51 Million
Q3 2016 Oct 25, 2017	BUY	N/A	7,568	7,568 $3.38 Million

Others Institutions Holding REGN

# of Institutions

1,443

Shares Held

84.8M

Call Options Held

1.4M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $59.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History